Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
D031841:Aconitum / Q000037:antagonists & inhibitors; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D004048:Diethylamines / Q000494:pharmacology; D004206:Disopyramide / Q000494:pharmacology*; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006168:Guinea Pigs; D006327:Heart Block / Q000139:chemically induced; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D007097:Imines / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D010069:Oxadiazoles / Q000494:pharmacology*; D010208:Papaverine / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013328:Strophanthins / Q000037:antagonists & inhibitors
D000889:Anti-Arrhythmia Agents; D004048:Diethylamines; D007097:Imines; D010069:Oxadiazoles; D011725:Pyridines; D013328:Strophanthins; D008012:Lidocaine; D010208:Papaverine; D004206:Disopyramide; D004837:Epinephrine